ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2258

Risk Factors for Total Joint Replacement in Systemic Lupus Erythematosus Patients with Avascular Necrosis

Jennifer Lee1, Dae-Jun Kim1, Jae Ho Lee1, Seung Min Jung1, Seung-Ki Kwok1, Ji Hyeon Ju2, Kyung-Su Park1, Sung-Hwan Park1 and Ho-Youn Kim1, 1Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea, 2Rheumatology, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: avascular necrosis and systemic lupus erythematosus (SLE), Joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Avascular necrosis (AVN) is a common manifestation in patients with systemic lupus erythematosus (SLE) and is associated with significant morbidity. A number of studies have been conducted to elucidate the risk factors for the development of AVN. However, clinical outcomes of AVN in patients with SLE have not been highlighted. We aimed to determine the clinical features predictive of the development of AVN in SLE patients and to elucidate the risk factors for the total joint replacement (TJR) of the affected joints in SLE patients with AVN.

Methods: The medical records of 938 patients with SLE admitted to a single center in Seoul, Korea from January 1990 to April 2012 were reviewed and 66 patients with AVN were identified. A hundred and one age-and sex-matched patients with SLE who didn’t have apparent AVN were included as disease controls. The independent risk factors for the development of AVN were examined by univariate and multivariate logistic regression analyses. The timing and cumulative risk of TJR were identified by Kaplan-Meier methods. The independent risk factors for TJR were determined by univariate and multivariate Cox proportional hazards regression analyses.

Results: The prevalence AVN was 7.0%. Multivariate logistic regression analysis revealed that the independent risk factors for the development of AVN included discoid rash (odds ratio (OR) 7.861, p=0.022), lymphopenia (OR 12.316, p=0.003), cushingoid feature (OR 3.029, p=0.02). Among 66 patients with AVN, 61 had AVN of the hip, 10 had AVN of knee and 1 had AVN of shoulder. Thirty-eight patients underwent total joint replacement (TJR) surgery. In univariate analysis, male patients, bilateral joint involvement, neuropsychiatric lupus, renal involvement, advanced radiological stage of AVN (Association for Research on Osseous Circulation (ARCO) stage) at the time of diagnosis were included as predictive risk factors for TJR. In multivariate analysis, only advanced radiological stage of AVN at the time of diagnosis was included as an independent risk factor for TJR (hazard ratio 2.464, p=0.038).

Conclusion: Our results demonstrated that advanced radiological stage at the onset of AVN is an independent predictable risk factor for TJR in SLE patients with AVN.


Disclosure:

J. Lee,
None;

D. J. Kim,
None;

J. H. Lee,
None;

S. M. Jung,
None;

S. K. Kwok,
None;

J. H. Ju,
None;

K. S. Park,
None;

S. H. Park,
None;

H. Y. Kim,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-total-joint-replacement-in-systemic-lupus-erythematosus-patients-with-avascular-necrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology